생체 재료 창상 드레싱 시장 - 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Biomaterial Wound Dressing Market Size, Share & Trends Analysis Report By Product (Natural, Synthetic), By Application (Chronic Wounds, Acute Wounds), By End-use, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,443,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,862,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,700,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

생체 재료 창상 드레싱 시장의 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 세계의 생체 재료 창상 드레싱 시장은 예측 기간 동안 CAGR 7.46%로 성장을 지속할 전망이며, 2030년까지 102억 1,000만 달러에 이를 것으로 예상됩니다. 혁신적이고 효과적인 상처 케어 제품의 개발로 이어진 생체 재료 기술의 발전, 만성 질환의 유병률 상승, 신흥 경제 국가의 의료 인프라 개선이 예측 기간에 걸쳐 생체 재료 창상 드레싱 시장을 추진 하는 주요 원동력이 되고 있습니다.

게다가 주요 기업에 의한 제품 출시 증가 및 연구개발 활동의 활성화에 의해 생체 재료 창상 드레싱 시장은 최근 수십 년간 큰 성장을 이루고 있습니다. 예를 들어, 2023년 1월, Convatec은 의료 종사자와 환자 요구에 부응하는 고급 폼 드레싱 시리즈인 ConvaFoam을 발표했습니다. ConvaFoam은 다재다능하고 상처의 치유 단계에 관계없이 다양한 유형의 상처에 사용할 수 있기 때문에 상처 관리 및 피부 보호에 이상적인 드레싱 옵션입니다.

마찬가지로 2023년 8월, Medela는 폐쇄된 수술 절개를 포함한 모든 유형의 상처를 수용하도록 설계된 Invia Integrated Dressing을 출시했습니다. 이 멸균 드레싱은 병원과 집 모두에서 최대 7일 동안 사용할 수 있습니다. 그 결과, 다른 혜택을 갖춘 제품의 출시는 예측 기간 동안 이러한 생체 재료 창상 드레싱 시장 성장을 확대할 것으로 예상됩니다.

당뇨병 및 비만과 같은 만성 질환 증가로 만성 상처를 가진 환자가 증가하고 있습니다. 생체 재료 창상 드레싱는 이러한 상처의 치료에 효과적인 것으로 알려져 있으며, 이것이 이 제품 수요를 밀어 올리고 있습니다. 예를 들어 WHO에 따르면 2023년 당뇨병은 세계의 건강 문제이며, 세계 전체에서 약 4억 2,200만 명이 이환되어, 그 대부분이 중저소득국입니다. 매년 150만 명이 당뇨병이 직접적인 원인으로 사망하고 있습니다. 당뇨병의 유병률과 환자 수는 지난 수십년동안 꾸준히 증가했습니다. 이러한 요인들은 예측 기간 동안 시장 성장을 가속할 것으로 예상됩니다.

생체 재료 창상 드레싱 시장 보고서 하이라이트

• 제품별로 천연 상처 피복 부문은 2023년 최대 시장 점유율을 차지했습니다. 이 성장은 당뇨병성 발궤양 및 욕창 발생 건수 증가에 의해 예측할 수 있습니다.
• 용도별로는 만성상처 부문이 2023년 최대 시장 점유율을 차지했는데, 이는 만성상처 증가와 함께 노인 인구 증가가 이 부문의 성장을 견인하고 있기 때문입니다.
• 최종 용도에서는 병원 부문이 2023년에 가장 큰 점유율을 차지했습니다. 병원에서는 환자의 결과를 최적화하기 위해 고급 상처 케어 기술과 치료법을 채택하는 경우가 많습니다.
• 북미는 헬스케어 인프라가 발달하고 있으며 주요 기업이 많이 진출하고 있기 때문에 예측기간을 통해 생체 재료 창상 드레싱 시장의 성장을 지배할 것으로 보입니다.

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 생체 재료 창상 드레싱 시장의 변수, 동향 및 범위

• 시장 계통 전망
  • 상위 시장 전망
  • 관련 및 부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 생체 재료 창상 드레싱 시장 분석 툴
  • Porter's Five Forces 분석
  • PESTEL 분석

제4장 생체 재료 창상 드레싱 시장 : 제품별 추정 및 동향 분석

• 부문 대시보드
• 세계의 생체 재료 창상 드레싱 시장 : 제품별 변동 분석(100만 달러)(2023년, 2030년)
• 세계의 생체 재료 창상 드레싱 시장 규모 및 동향 분석 : 제품별(2018-2030년)
• 자연
• 합성

제5장 생체 재료 창상 드레싱 시장 : 용도별 추정 및 동향 분석

• 부문 대시보드
• 생체 재료 창상 드레싱 시장 : 용도별 변동 분석(100만 달러)(2023년, 2030년)
• 세계의 생체 재료 창상 드레싱 시장 규모 및 동향 분석 : 용도별(2018-2030년)
• 만성 상처
• 급성 상처

제6장 생체 재료 창상 드레싱 시장 : 최종 용도별 추정 및 동향 분석

• 부문 대시보드
• 생체 재료 창상 드레싱 시장 : 최종 용도별 변동 분석(100만 달러)(2023년, 2030년)
• 세계의 생체 재료 창상 드레싱 시장 규모 및 동향 분석 : 최종 용도별(2018-2030년)
• 병원
• 외래 시설
• 재택 헬스케어
• 조사 및 제조

제7장 생체 재료 창상 드레싱 시장 : 제품별, 용도별, 최종 용도별, 지역별 추정 및 동향 분석

• 지역 대시보드
• 시장 규모 및 동향 분석(2018-2030년)
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제8장 경쟁 구도

• 주요 시장 진출기업에 의한 최근의 동향 및 영향 분석
• 기업의 분류
• 기업의 시장 점유율 분석
• 기업 히트맵 분석
• 전략 매핑
  • 확대
  • 합병 및 인수
  • 파트너십 및 협업
  • 신제품 발매
  • 연구개발
  • 기업 프로파일
  • ConvaTec Group PLC
  • Smith & Nephew PLC
  • Molnlycke Health Care AB
  • B. Braun Melsungen AG
  • 3M
  • URGO Medical
  • Coloplast Corp.
  • Integra LifeSciences
  • Medline Industries, Inc.
  • Medline Industries, Inc.

AJY

영문 목차

영문목차

Biomaterial Wound Dressing Market Growth & Trends:

The global biomaterial wound dressing market is expected to reach USD 10.21 billion by 2030, registering a CAGR of 7.46% in the forecast period, according to a new report by Grand View Research, Inc. Advances in biomaterial technology, which have led to the development of innovative and effective wound care products, rising prevalence of chronic diseases, improving healthcare infrastructure in emerging economies, are the key driving factors propel the biomaterial wound dressing market over the forecast period.

Moreover, the biomaterial wound dressing market has seen significant growth over the last few decades, owing to increasing product launches by key players, and rising R&D activities. For instance, in January 2023, Convatec introduced ConvaFoam, a range of advanced foam dressings that cater to the requirements of both healthcare providers and patients. ConvaFoam's versatility makes it an ideal dressing option for managing wounds and safeguarding the skin, as it can be used for various wound types, regardless of the wound's healing stage.

Similarly, in August 2023, Medela launched the Invia Integrated Dressing, which is designed to cater to all types of wounds, including closed surgical incisions. The sterile dressing can be utilized in both hospital and home settings for a period of up to seven days. As a result, product launches with additional benefits are expected to increase market growth for these biomaterial wound dressings over the projection period.

The rising prevalence of chronic disorders, such as diabetes and obesity has led to an increase in the number of patients with chronic wounds. Biomaterial wound dressings have been found to be effective in treating these wounds, which has driven demand for these products. For instance, according to WHO, in 2023, diabetes is a global health concern, with approximately 422 million people affected globally, mostly in low- and middle-income countries. Every year, 1.5 million deaths are directly linked to diabetes. The prevalence and number of cases of diabetes have been on a steady rise over the past few decades. These factors are expected to drive market growth over the forecast period.

Biomaterial Wound Dressing Market Report Highlights:

• In terms of product, natural wound dressing segment held the largest market share in 2023. This growth can be anticipated due to the rising incidences of diabetic foot ulcers and pressure ulcers
• In terms of application, the chronic wounds segment held the largest market share in 2023, owing to rising geriatric populations along with the rising chronic wounds are driving the segment growth
• In terms of end use, hospitals segment held the largest share in 2023. Hospitals often adopt advanced wound care technologies and treatments to optimize patient outcomes
• North America is expected to dominate the biomaterial wound dressing market growth over the forecast period owing to the well-developed healthcare infrastructure and large presence of key players operating in the market

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
• 1.5. Details of primary research
  • 1.5.1. Data for primary interviews in North America
  • 1.5.2. Data for primary interviews in Europe
  • 1.5.3. Data for primary interviews in Asia Pacific
  • 1.5.4. Data for primary interviews in Latin America
  • 1.5.5. Data for Primary interviews in MEA
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.1.1. Approach 1: Commodity flow approach
  • 1.7.2. Volume price analysis (Model 2)
    • 1.7.2.1. Approach 2: Volume price analysis
• 1.8. Research Scope and Assumptions
  • 1.8.1. List of Secondary Sources
  • 1.8.2. List of Primary Sources
  • 1.8.3. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Biomaterial Wound Dressing Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Drivers Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Increasing number of accidents
    • 3.2.1.3. Rising geriatric population
    • 3.2.1.4. Technological advancements in wound dressings
  • 3.2.2. Market Restraints Analysis
    • 3.2.2.1. Stringent manufacturing policies
• 3.3. Biomaterial Wound Dressing Market Analysis Tools
  • 3.3.1. Porter's Analysis
    • 3.3.1.1. Bargaining power of the suppliers
    • 3.3.1.2. Bargaining power of the buyers
    • 3.3.1.3. Threats of substitution
    • 3.3.1.4. Threats from new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
    • 3.3.2.5. Legal landscape

Chapter 4. Biomaterial Wound Dressing Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Biomaterial Wound Dressing Market: Product Movement Analysis, USD Million, 2023 & 2030
• 4.3. Global Biomaterial Wound Dressing Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Natural
  • 4.4.1. Natural market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Alginate
    • 4.4.2.1. Alginate market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.3. Honey
    • 4.4.3.1. Honey market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.4. Collagen
    • 4.4.4.1. Collagen market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.5. Chitosan
    • 4.4.5.1. Chitosan market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.4.6. Carboxymethyl cellulose (CMC)
    • 4.4.6.1. Carboxymethyl cellulose (CMC) market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.4.7. Others
    • 4.4.7.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
• 4.5. Synthetic
  • 4.5.1. Synthetic market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Polyurethane
    • 4.5.2.1. Polyurethane market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.5.3. Silicone
    • 4.5.3.1. Silicone market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 4.5.4. Others
    • 4.5.4.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)

Chapter 5. Biomaterial Wound Dressing Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Biomaterial Wound Dressing Market: Application Movement Analysis, USD Million, 2023 & 2030
• 5.3. Global Biomaterial Wound Dressing Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 5.4. Chronic Wounds
  • 5.4.1. Chronic wounds market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.4.2. Diabetic foot ulcer
    • 5.4.2.1. Diabetic foot ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.4.3. Pressure ulcer
    • 5.4.3.1. Pressure ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.4.4. Venous leg ulcer
    • 5.4.4.1. Venous leg ulcer market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.4.5. Others
    • 5.4.5.1. Others market revenue estimates and forecasts, 2018 - 2030 (USD million)
• 5.5. Acute Wounds
  • 5.5.1. Acute wounds market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5.2. Surgical & traumatic wounds
    • 5.5.2.1. Surgical & traumatic wounds market revenue estimates and forecasts, 2018 - 2030 (USD million)
  • 5.5.3. Burns
    • 5.5.3.1. Burns market revenue estimates and forecasts, 2018 - 2030 (USD million)

Chapter 6. Biomaterial Wound Dressing Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Biomaterial Wound Dressing Market: End Use Movement Analysis, USD Million, 2023 & 2030
• 6.3. Global Biomaterial Wound Dressing Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 6.4. Hospitals
  • 6.4.1. Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.5. Outpatient Facilities
  • 6.5.1. Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.6. Home healthcare
  • 6.6.1. Home healthcare market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• 6.7. Research & Manufacturing
  • 6.7.1. Research & manufacturing market revenue estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7. Biomaterial Wound Dressing Market: Regional Estimates & Trend Analysis by Product, Application, & End Use

• 7.1. Regional Dashboard
• 7.2. Market Size and Trend Analysis, 2018 to 2030
• 7.3. North America
  • 7.3.1. North America biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Competitive scenario
    • 7.3.2.3. Regulatory framework
    • 7.3.2.4. Reimbursement scenario
    • 7.3.2.5. U.S. biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key country dynamics
    • 7.3.3.2. Competitive scenario
    • 7.3.3.3. Regulatory framework
    • 7.3.3.4. Reimbursement scenario
    • 7.3.3.5. Canada biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Competitive scenario
    • 7.4.2.3. Regulatory framework
    • 7.4.2.4. Reimbursement scenario
    • 7.4.2.5. UK biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Competitive scenario
    • 7.4.3.3. Regulatory framework
    • 7.4.3.4. Reimbursement scenario
    • 7.4.3.5. Germany biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Competitive scenario
    • 7.4.4.3. Regulatory framework
    • 7.4.4.4. Reimbursement scenario
    • 7.4.4.5. France biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Competitive scenario
    • 7.4.5.3. Regulatory framework
    • 7.4.5.4. Reimbursement scenario
    • 7.4.5.5. Italy biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Competitive scenario
    • 7.4.6.3. Regulatory framework
    • 7.4.6.4. Reimbursement scenario
    • 7.4.6.5. Spain biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Competitive scenario
    • 7.4.7.3. Regulatory framework
    • 7.4.7.4. Reimbursement scenario
    • 7.4.7.5. Sweden biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Competitive scenario
    • 7.4.8.3. Regulatory framework
    • 7.4.8.4. Reimbursement scenario
    • 7.4.8.5. Denmark biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key country dynamics
    • 7.4.9.2. Competitive scenario
    • 7.4.9.3. Regulatory framework
    • 7.4.9.4. Reimbursement scenario
    • 7.4.9.5. Norway biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Competitive scenario
    • 7.5.2.3. Regulatory framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. China biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Japan
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Competitive scenario
    • 7.5.3.3. Regulatory framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Japan biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Competitive scenario
    • 7.5.4.3. Regulatory framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. India biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Competitive scenario
    • 7.5.5.3. Regulatory framework
    • 7.5.5.4. Reimbursement scenario
    • 7.5.5.5. South Korea biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Competitive scenario
    • 7.5.6.3. Regulatory framework
    • 7.5.6.4. Reimbursement scenario
    • 7.5.6.5. Australia biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key country dynamics
    • 7.5.7.2. Competitive scenario
    • 7.5.7.3. Regulatory framework
    • 7.5.7.4. Reimbursement scenario
    • 7.5.7.5. Thailand biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Competitive scenario
    • 7.6.2.3. Regulatory framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. Brazil biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Mexico
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Competitive scenario
    • 7.6.3.3. Regulatory framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Mexico biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Argentina
    • 7.6.4.1. Key country dynamics
    • 7.6.4.2. Competitive scenario
    • 7.6.4.3. Regulatory framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. Argentina biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
• 7.7. Middle East and Africa
  • 7.7.1. Middle East and Africa biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Competitive scenario
    • 7.7.2.3. Regulatory framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Saudi Arabia biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Competitive scenario
    • 7.7.3.3. Regulatory framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. UAE biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. South Africa
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Competitive scenario
    • 7.7.4.3. Regulatory framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. South Africa biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key country dynamics
    • 7.7.5.2. Competitive scenario
    • 7.7.5.3. Regulatory framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. Kuwait biomaterial wound dressing market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Market Share Analysis
• 8.4. Company Heat Map Analysis
• 8.5. Strategy Mapping
  • 8.5.1. Expansion
  • 8.5.2. Mergers & Acquisition
  • 8.5.3. Partnerships & Collaborations
  • 8.5.4. New Product Launches
  • 8.5.5. Research And Development
  • 8.5.6. Company Profiles
  • 8.5.7. ConvaTec Group PLC
    • 8.5.7.1. Company overview
    • 8.5.7.2. Financial performance
    • 8.5.7.3. Product Benchmarking
    • 8.5.7.4. Strategic initiatives
  • 8.5.8. Smith & Nephew PLC
    • 8.5.8.1. Company overview
    • 8.5.8.2. Financial performance
    • 8.5.8.3. Product Benchmarking
    • 8.5.8.4. Strategic initiatives
  • 8.5.9. Molnlycke Health Care AB
    • 8.5.9.1. Company overview
    • 8.5.9.2. Financial performance
    • 8.5.9.3. Product Benchmarking
    • 8.5.9.4. Strategic initiatives
  • 8.5.10. B. Braun Melsungen AG
    • 8.5.10.1. Company overview
    • 8.5.10.2. Financial performance
    • 8.5.10.3. Product Benchmarking
    • 8.5.10.4. Strategic initiatives
  • 8.5.11. 3M
    • 8.5.11.1. Company overview
    • 8.5.11.2. Financial performance
    • 8.5.11.3. Product Benchmarking
    • 8.5.11.4. Strategic initiatives
  • 8.5.12. URGO Medical
    • 8.5.12.1. Company overview
    • 8.5.12.2. Financial performance
    • 8.5.12.3. Product Benchmarking
    • 8.5.12.4. Strategic initiatives
  • 8.5.13. Coloplast Corp.
    • 8.5.13.1. Company overview
    • 8.5.13.2. Financial performance
    • 8.5.13.3. Product Benchmarking
    • 8.5.13.4. Strategic initiatives
  • 8.5.14. Integra LifeSciences
    • 8.5.14.1. Company overview
    • 8.5.14.2. Financial performance
    • 8.5.14.3. Product Benchmarking
    • 8.5.14.4. Strategic initiatives
  • 8.5.15. Medline Industries, Inc.
    • 8.5.15.1. Company overview
    • 8.5.15.2. Financial performance
    • 8.5.15.3. Product Benchmarking
    • 8.5.15.4. Strategic initiatives

관련자료